Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes

Eike Steidl*, Karl-Josef Langen, Sarah Abu Hmeidan, Nenad Polomac, Christian P. Filss, Norbert Galldiks, Philipp Lohmann, Fee Keil, Katharina Filipski, Felix M. Mottaghy, Nadim Jon Shah, Joachim P. Steinbach, Elke Hattingen, Gabriele D. Maurer

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1956-1965
Number of pages10
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume48
Issue number6
Early online date26 Nov 2020
DOIs
Publication statusPublished - Jun 2021

Keywords

  • Glioma
  • PWI
  • [F-18]FET PET
  • Pseudoprogression
  • Isocitrate dehydrogenase
  • CEREBRAL BLOOD-VOLUME
  • DIAGNOSTIC-ACCURACY
  • FET-PET
  • GRADE
  • GLIOBLASTOMA
  • RECURRENCE
  • PSEUDOPROGRESSION
  • RECOMMENDATIONS

Cite this